Name: Tissue-type plasminogen activator Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Tissue-type plasminogen activator Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Razaxaban	Ki	33000.0 ^[1]
	6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine	IC50	125000.0 ^[1]
	6-(N-Phenylcarbamyl)-2-naphthalenecarboxamidine	Ki	31800.0 ^[1], 32000.0 ^[2]
	3-{5-[Amino(iminio)methyl]-1H-indol-2-YL}-1,1'-biphenyl-2-olate	Ki	35.0 ^[1], 100.0 ^[2]
	Amiloride	IC50	220000.0 ^[1], 250000.0 ^[2]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ Tissue-type plasminogen activator Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Dec. 2025, https://www.aatbio.com/data-sets/tissue-type-plasminogen-activator-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 21). Quest Database™ Tissue-type plasminogen activator Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tissue-type-plasminogen-activator-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan